Forte Capital LLC Gilead Sciences, Inc. Transaction History

Forte Capital LLC

$796 Million
Q1 2024

A detailed history of Forte Capital LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Forte Capital LLC holds 3,800 shares of GILD stock, worth $253,422. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,800

Previous 3,800 -0.0%

Holding current value

$253,422

Previous $307,000 9.45%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $4,396 - $4,985	-60 Reduced 1.55%	3,800 $307,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $15,202 - $17,340	-200 Reduced 4.93%	3,860 $297,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $99,712 - $143,152	-1,600 Reduced 28.27%	4,060 $348,000
Q3 2022 Oct 21, 2022	SELL	$59.54 - $68.01 $83,356 - $95,214	-1,400 Reduced 19.83%	5,660 $349,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $287,676 - $324,009	-4,984 Reduced 41.38%	7,060 $436,000

Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $47,038 - $53,389	-725 Reduced 5.68%	12,044 $875,000
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $225,960 - $257,820	-3,766 Reduced 22.78%	12,769 $825,000
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $70,982 - $80,881	-1,253 Reduced 7.04%	16,535 $963,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $779,044 - $979,513	-12,545 Reduced 41.36%	17,788 $1.12 Million
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $130,139 - $151,116	-1,799 Reduced 5.6%	30,333 $2.33 Million
Q1 2020 Apr 08, 2020	BUY	$62.63 - $80.22 $39,018 - $49,977	623 Added 1.98%	32,132 $2.4 Million
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $18,486 - $20,334	-300 Reduced 0.94%	31,509 $2.05 Million
Q3 2019 Oct 09, 2019	BUY	$62.51 - $69.0 $34,380 - $37,950	550 Added 1.76%	31,809 $2.02 Million
Q2 2019 Jul 16, 2019	BUY	$61.87 - $69.38 $7,238 - $8,117	117 Added 0.38%	31,259 $2.11 Million
Q1 2019 Apr 08, 2019	SELL	$62.53 - $70.05 $36,454 - $40,839	-583 Reduced 1.84%	31,142 $2.03 Million
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $75,675 - $98,750	-1,250 Reduced 3.79%	31,725 $1.98 Million
Q2 2018 Jul 13, 2018	SELL	$64.88 - $75.68 $11,678 - $13,622	-180 Reduced 0.54%	32,975 $2.34 Million
Q1 2018 Apr 17, 2018	SELL	$72.84 - $88.8 $18,210 - $22,200	-250 Reduced 0.75%	33,155 $2.5 Million
Q4 2017 Jan 22, 2018	BUY	$71.15 - $83.52 $10,672 - $12,528	150 Added 0.45%	33,405 $2.39 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $2.4 Million - $2.84 Million	33,255	33,255 $2.69 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.

Account

Forte Capital LLC Gilead Sciences, Inc. Transaction History